1. AB0743 Low rates of major adverse cardiac events, malignancies, and serious infections in patients with psoriasis and psoriatic arthritis treated with apremilast for ≥156 weeks: pooled analysis from the esteem and palace 1-3 phase 3 trials. (15th June 2017) Authors: Kavanaugh, A; Augustin, M; Lespessailles, E; Papp, KA; Paris, M; Chen, R; Gladman, DD; Pariser, DM; Peris, K Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗